Literature DB >> 16562137

Properties of a Mutant of Escherichia coli with a Temperature-sensitive Fructose-1,6-Diphosphate Aldolase.

A Böck1, F C Neidhardt.   

Abstract

Böck, August (Purdue University, Lafayette, Ind.), and Frederick C. Neidhardt. Properties of a mutant of Escherichia coli with a temperature-sensitive fructose-1,6-diphosphate aldolase. J. Bacteriol. 92:470-476. 1966.-A mutant of Escherichia coli in which fructose-1,6-diphosphate aldolase functions at 30 C but not at 40 C was used to study the physiological effect of a specific block in the Embden-Meyerhof glycolytic pathway. Growth of the mutant at 40 C was found to be inhibited by the presence of glucose or certain related compounds in the medium. At 40 C, glucose was metabolized at 30 to 40% of the control rate and was abnormal in that glucose was converted into other six-carbon substances (probably gluconate, in large part) that were released into the culture medium. The inhibition was complete, but transient; its duration depended upon the initial amount of inhibitor added. The resumption of growth at 40 C was correlated with the further catabolism of the excreted compounds. When glycerol was used to grow the mutant at 40 C, the growth inhibition by glucose was accompanied by cessation of glycerol metabolism. Growth on alpha-glycerol phosphate was not inhibited under these conditions, implicating glycerol kinase as a possible site of inhibition; no inhibition of glycerol kinase by sugar phosphates, however, could be detected in vitro. The inhibitory effect of glucose on growth at 40 C is not caused by a deficit of intracellular adenosine triphosphate, but may be the result of a generalized poisoning of many cell processes by a greatly increased intracellular concentration of fructose-1,6-diphosphate, the substrate of the damaged enzyme.

Entities:  

Year:  1966        PMID: 16562137      PMCID: PMC276265          DOI: 10.1128/jb.92.2.470-476.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  19 in total

1.  Utilization of L-alpha-glycerophosphate by Escherichia coli without hydrolysis.

Authors:  E C LIN; J P KOCH; T M CHUSED; S E JORGENSEN
Journal:  Proc Natl Acad Sci U S A       Date:  1962-12-15       Impact factor: 11.205

2.  Studies on the induction of beta-galactosidase in a cryptic strain of Escherichia coli.

Authors:  L A HERZENBERG
Journal:  Biochim Biophys Acta       Date:  1959-02

3.  Interference with growth of certain Escherichia coli mutants by galactose.

Authors:  K KURAHASHI; A J WAHBA
Journal:  Biochim Biophys Acta       Date:  1958-11

4.  Mutation to L-rhamnose resistance and transduction to L-rhamnose utilization in Salmonella typhosa.

Authors:  E ENGLESBERG; L S BARON
Journal:  J Bacteriol       Date:  1959-11       Impact factor: 3.490

5.  The measurement of luciferin and luciferase.

Authors:  A M CHASE
Journal:  Methods Biochem Anal       Date:  1960

6.  Some disturbances of erythrocyte metabolism in galactosaemia.

Authors:  V SCHWARZ; L GOLBERG; G M KOMROWER; A HOLZEL
Journal:  Biochem J       Date:  1956-01       Impact factor: 3.857

7.  Synthesis of phosphatides in isolated mitochondria. III. The enzymatic phosphorylation of glycerol.

Authors:  C BUBLITZ; E P KENNEDY
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

8.  Enzymatic basis of mannose toxicity in honey bees.

Authors:  A SOLS; E CADENAS; F ALVARADO
Journal:  Science       Date:  1960-01-29       Impact factor: 47.728

9.  L-Arabinose-sensitive, L-ribulose 5-phosphate 4-epimerase-deficient mutants of Escherichia coli.

Authors:  E ENGLESBERG; R L ANDERSON; R WEINBERG; N LEE; P HOFFEE; G HUTTENHAUER; H BOYER
Journal:  J Bacteriol       Date:  1962-07       Impact factor: 3.490

10.  Growth stasis by accumulated L-alpha-glycerophosphate in Escherichia coli.

Authors:  N R Cozzarelli; J P Koch; S Hayashi; E C Lin
Journal:  J Bacteriol       Date:  1965-11       Impact factor: 3.490

View more
  33 in total

1.  Physiological effects of the fructose-1,6-diphosphate aldolase ts8 mutation on stable RNA synthesis in Escherichia coli.

Authors:  M Singer; W A Walter; B M Cali; P Rouviere; H H Liebke; R L Gourse; C A Gross
Journal:  J Bacteriol       Date:  1991-10       Impact factor: 3.490

2.  The Escherichia coli ts8 mutation is an allele of fda, the gene encoding fructose-1,6-diphosphate aldolase.

Authors:  M Singer; P Rossmiessl; B M Cali; H Liebke; C A Gross
Journal:  J Bacteriol       Date:  1991-10       Impact factor: 3.490

3.  Fructose-1,6-bisphosphate aldolase (class II) is the primary site of nickel toxicity in Escherichia coli.

Authors:  Lee Macomber; Scott P Elsey; Robert P Hausinger
Journal:  Mol Microbiol       Date:  2011-11-08       Impact factor: 3.501

4.  The utilisation of D-galactonate and D-2-oxo-3-deoxygalactonate by Escherichia coli K-12. Biochemical and genetical studies.

Authors:  R A Cooper
Journal:  Arch Microbiol       Date:  1978-08-01       Impact factor: 2.552

5.  Toxoplasma aldolase is required for metabolism but dispensable for host-cell invasion.

Authors:  Bang Shen; L David Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

6.  Physiological basis of transient repression of catabolic enzymes in Escherichia coli.

Authors:  B Tyler; B Magasanik
Journal:  J Bacteriol       Date:  1970-05       Impact factor: 3.490

7.  Saccharomyces cerevisiae aldolase mutants.

Authors:  Z Lobo
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

8.  Pyruvate kinase mutants of Saccharomyces cerevisiae: biochemical and genetic characterisation.

Authors:  P K Maitra; Z Lobo
Journal:  Mol Gen Genet       Date:  1977-04-29

9.  2-keto-3-deoxygluconate 6-phosphate aldolase mutants of Escherichia coli.

Authors:  J E Fradkin; D G Fraenkel
Journal:  J Bacteriol       Date:  1971-12       Impact factor: 3.490

10.  Biochemical characterization of a fructokinase mutant of Rhizobium meliloti.

Authors:  A Gardiol; A Arias; C Cerveñansky; C Gaggero; G Martínez-Drets
Journal:  J Bacteriol       Date:  1980-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.